BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu K, Liu LM, Farazi PA, Wang H, Rochling FA, Watanabe-Galloway S, Zhang JJ. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Glob Health Action 2018;11:1433987. [PMID: 29447614 DOI: 10.1080/16549716.2018.1433987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Chen P, Zheng C. Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B. Infect Drug Resist 2018;11:2179-85. [PMID: 30519055 DOI: 10.2147/IDR.S186719] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Jiang D, Zhang L, Liu W, Ding Y, Yin J, Ren R, Li Q, Chen Y, Shen J, Tan X, Zhang H, Cao G. Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study. Cancer Commun (Lond) 2021. [PMID: 34251754 DOI: 10.1002/cac2.12195] [Reference Citation Analysis]
3 Shi H, Xiao G, Liao M, Zheng L, Jie Y, Lin G, Chong Y. Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failure. Biomed Pharmacother 2021;134:111118. [PMID: 33341047 DOI: 10.1016/j.biopha.2020.111118] [Reference Citation Analysis]
4 Dai Z, Wong IOL, Xie C, Xu W, Xiang Y, Peng L, Lau EHY. Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China. Clin Microbiol Infect 2021:S1198-743X(21)00344-X. [PMID: 34197929 DOI: 10.1016/j.cmi.2021.06.024] [Reference Citation Analysis]
5 Kong LN, He S, Li L, Lei QS, Wang T, Yao Y. Factors for self-management activities among rural patients with chronic hepatitis B: A cross-sectional study. J Clin Nurs 2019;28:3949-56. [PMID: 31408559 DOI: 10.1111/jocn.15037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Kong LN, Yao Y, Li L, Zhao QH, Wang T, Li YL. Psychological distress and self-management behaviours among patients with chronic hepatitis B receiving oral antiviral therapy. J Adv Nurs 2021;77:266-74. [PMID: 33074555 DOI: 10.1111/jan.14610] [Reference Citation Analysis]
7 Kong LN, Zhu WF, Li L, Lei QS, Wang T, Li YL. Self-management behaviors in adults with chronic hepatitis B: A structural equation model. Int J Nurs Stud 2021;116:103382. [PMID: 31402047 DOI: 10.1016/j.ijnurstu.2019.06.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. "To die is better than to tell": reasons for and against disclosure of chronic hepatitis B status in Ghana. BMC Public Health 2020;20:663. [PMID: 32398150 DOI: 10.1186/s12889-020-08811-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cui Y, Moriyama M, Chayama K, Liu Y, Ya C, Muzembo BA, Rahman MM. Efficacy of a self-management program in patients with chronic viral hepatitis in China. BMC Nurs 2019;18:44. [PMID: 31548833 DOI: 10.1186/s12912-019-0366-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
10 Cho EJ, Yu SJ, Kwon SY, Kim JH, Kim DY, Kim W, Lee JS, Lee JW, Lee YJ, Chae HB, Yoon JH. Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial. Drug Des Devel Ther 2018;12:3767-74. [PMID: 30464407 DOI: 10.2147/DDDT.S181561] [Reference Citation Analysis]